1. Home
  2. TIL vs PCQ Comparison

TIL vs PCQ Comparison

Compare TIL & PCQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIL
  • PCQ
  • Stock Information
  • Founded
  • TIL 2018
  • PCQ 2001
  • Country
  • TIL United States
  • PCQ United States
  • Employees
  • TIL N/A
  • PCQ N/A
  • Industry
  • TIL Biotechnology: Pharmaceutical Preparations
  • PCQ Investment Managers
  • Sector
  • TIL Health Care
  • PCQ Finance
  • Exchange
  • TIL Nasdaq
  • PCQ Nasdaq
  • Market Cap
  • TIL 218.4M
  • PCQ 185.3M
  • IPO Year
  • TIL 2021
  • PCQ N/A
  • Fundamental
  • Price
  • TIL $26.50
  • PCQ $9.70
  • Analyst Decision
  • TIL Buy
  • PCQ
  • Analyst Count
  • TIL 4
  • PCQ 0
  • Target Price
  • TIL $100.33
  • PCQ N/A
  • AVG Volume (30 Days)
  • TIL 154.7K
  • PCQ 69.6K
  • Earning Date
  • TIL 11-13-2024
  • PCQ 01-01-0001
  • Dividend Yield
  • TIL N/A
  • PCQ 4.63%
  • EPS Growth
  • TIL N/A
  • PCQ N/A
  • EPS
  • TIL N/A
  • PCQ N/A
  • Revenue
  • TIL N/A
  • PCQ N/A
  • Revenue This Year
  • TIL N/A
  • PCQ N/A
  • Revenue Next Year
  • TIL $2.64
  • PCQ N/A
  • P/E Ratio
  • TIL N/A
  • PCQ N/A
  • Revenue Growth
  • TIL N/A
  • PCQ N/A
  • 52 Week Low
  • TIL $6.08
  • PCQ $8.19
  • 52 Week High
  • TIL $92.00
  • PCQ $10.50
  • Technical
  • Relative Strength Index (RSI)
  • TIL 38.29
  • PCQ 41.32
  • Support Level
  • TIL $24.31
  • PCQ $9.60
  • Resistance Level
  • TIL $37.24
  • PCQ $9.93
  • Average True Range (ATR)
  • TIL 4.02
  • PCQ 0.12
  • MACD
  • TIL 0.26
  • PCQ -0.02
  • Stochastic Oscillator
  • TIL 10.85
  • PCQ 24.39

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

About PCQ PIMCO California Municipal Income Fund

PIMCO California Municipal Income Fund is a closed-end management investment company. It seeks to provide current income exempt from federal and California income tax. The fund makes investments in different sectors such as healthcare, property, education, Natural Gas, and others.

Share on Social Networks: